共 50 条
- [46] [177Lu]-PSMA-617 radionuclide therapy in patients with metastatic castration-resistant prostate cancer reply LANCET ONCOLOGY, 2018, 19 (08): : E373 - E373
- [49] Molecular analysis of circulating tumor cells of metastatic castration-resistant Prostate Cancer Patients receiving 177Lu-PSMA-617 Radioligand Therapy THERANOSTICS, 2020, 10 (17): : 7645 - 7655
- [50] Overall survival and response pattern of castration-resistant metastatic prostate cancer to multiple cycles of radioligand therapy using [177Lu]Lu-PSMA-617 European Journal of Nuclear Medicine and Molecular Imaging, 2017, 44 : 1448 - 1454